Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Total Assets

Latest as of March 2026: Rs3.17 Billion INR ≈ $34.25 Million USD

Based on the latest financial reports, Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) holds total assets worth Rs3.17 Billion INR (≈ $34.25 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see JAGSNPHARM operating cash flow for how efficiently the company converts equity into cash flow.

Jagsonpal Pharmaceuticals Limited - Total Assets Trend (2006–2026)

This chart illustrates how Jagsonpal Pharmaceuticals Limited's total assets have evolved over time, based on quarterly financial data. See JAGSNPHARM stock price for real-time trading data and today's change.

Jagsonpal Pharmaceuticals Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Jagsonpal Pharmaceuticals Limited's total assets of Rs3.17 Billion consist of 45.2% current assets and 54.8% non-current assets. Explore JAGSNPHARM net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	3.2%
Accounts Receivable	Rs171.91 Million	5.4%
Inventory	Rs146.43 Million	4.6%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs682.67 Million	21.6%
Goodwill	Rs96.93 Million	3.1%

Asset Composition Trend (2006–2026)

This chart illustrates how Jagsonpal Pharmaceuticals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Jagsonpal Pharmaceuticals Limited's current assets represent 45.2% of total assets in 2026, a decrease from 74.1% in 2006.
Cash Position: Cash and equivalents constituted 3.2% of total assets in 2026, up from 2.8% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 24.0% of total assets, an increase from 0.0% in 2006.
Asset Diversification: The largest asset category is intangible assets at 21.6% of total assets.

Jagsonpal Pharmaceuticals Limited Competitors by Total Assets

Key competitors of Jagsonpal Pharmaceuticals Limited based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	China	CN¥12.75 Billion
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd SHE:000766	China	CN¥4.71 Billion
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	China	CN¥13.81 Billion
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	China	CN¥7.28 Billion
Ningbo Menovo Pharm Co Ltd SHG:603538	China	CN¥4.73 Billion
PolyPeptide Group AG SW:PPGN	Switzerland	CHF773.07 Million
Lionco Pharm Grp Co Ltd SHG:603669	China	CN¥1.12 Billion

Jagsonpal Pharmaceuticals Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	5.06	6.22	2.98
Quick Ratio	4.54	5.64	2.25
Cash Ratio	0.00	0.00	0.00
Working Capital	Rs1.15 Billion	Rs1.35 Billion	Rs800.80 Million

Jagsonpal Pharmaceuticals Limited - Advanced Valuation Insights

This section examines the relationship between Jagsonpal Pharmaceuticals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	5.56
Latest Market Cap to Assets Ratio	0.05
Asset Growth Rate (YoY)	13.8%
Total Assets	Rs3.17 Billion
Market Capitalization	$156.15 Million USD

Valuation Analysis

Below Book Valuation: The market values Jagsonpal Pharmaceuticals Limited's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Jagsonpal Pharmaceuticals Limited's assets grew by 13.8% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Jagsonpal Pharmaceuticals Limited (2006–2026)

The table below shows the annual total assets of Jagsonpal Pharmaceuticals Limited from 2006 to 2026.

Year	Total Assets	Change
2026-03-31	Rs3.17 Billion ≈ $34.25 Million	+13.81%
2025-03-31	Rs2.78 Billion ≈ $30.09 Million	+28.18%
2024-03-31	Rs2.17 Billion ≈ $23.48 Million	+11.35%
2023-03-31	Rs1.95 Billion ≈ $21.08 Million	+15.73%
2022-03-31	Rs1.68 Billion ≈ $18.22 Million	+2.59%
2021-03-31	Rs1.64 Billion ≈ $17.76 Million	+11.74%
2020-03-31	Rs1.47 Billion ≈ $15.89 Million	+8.23%
2019-03-31	Rs1.36 Billion ≈ $14.68 Million	+4.60%
2018-03-31	Rs1.30 Billion ≈ $14.04 Million	-8.97%
2017-03-31	Rs1.43 Billion ≈ $15.42 Million	-10.47%
2016-03-31	Rs1.59 Billion ≈ $17.23 Million	+3.28%
2015-03-31	Rs1.54 Billion ≈ $16.68 Million	-1.30%
2014-03-31	Rs1.56 Billion ≈ $16.90 Million	+2.13%
2013-03-31	Rs1.53 Billion ≈ $16.55 Million	-1.98%
2012-03-31	Rs1.56 Billion ≈ $16.88 Million	+14.18%
2011-03-31	Rs1.37 Billion ≈ $14.79 Million	+10.94%
2010-03-31	Rs1.23 Billion ≈ $13.33 Million	+0.38%
2009-03-31	Rs1.23 Billion ≈ $13.28 Million	-5.74%
2008-03-31	Rs1.30 Billion ≈ $14.09 Million	-11.68%
2007-03-31	Rs1.47 Billion ≈ $15.95 Million	+4.19%
2006-03-31	Rs1.42 Billion ≈ $15.31 Million	--

About Jagsonpal Pharmaceuticals Limited

NSE:JAGSNPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$156.15 Million

Rs14.44 Billion INR

Market Cap Rank

#17472 Global

#929 in India

Share Price

Rs219.01

Change (1 day)

-2.16%

52-Week Range

Rs161.07 - Rs243.97

All Time High

Rs761.20